Reuters: Pfizer drug works on rare pancreatic cancer: study

[NaDiNe]

Pfizer drug works on rare pancreatic cancer: study
      
   
      

NEW YORK (Reuters) - A study of Pfizer Inc's Sutent was halted early after the medicine delayed progression of a rare form of pancreatic cancer affecting tens of thousands of people globally, including Apple Inc CEO Steve Jobs.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login